Atara Biotherapeutics Inc
ATRA
Market Cap$72.68M
Close$
$2.35
285.7% upside
Current Fair Value
285.7% upsideUndervalued by 285.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $72.68 Million |
|---|---|
| Enterprise Value | $68.64 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.03 |
| Beta | 3.0 |
| Outstanding Shares | 120,416,138 |
| Avg 30 Day Volume | 1,245,967 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | 0.54 |
| Price to Sales | - |
| Price to Book Ratio | -0.61 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.61 |
| Debt to Equity | -0.43 |
Revenue Sources
No data
ESG Score
No data
About Atara Biotherapeutics Inc
CEO: Pascal Touchon